Published

Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials

Title: Use of psilocybin in the treatment of mental disorders: systematic review of clinical trials. Objective: To evaluate the high-impact evidence on the neurobiology, efficacy, safety, and feasibility of using psilocybin in the treatment of mental disorders such as depression, anxiety, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), smoking, and alcoholism

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Complementary Medicine & Alternative Healthcare
Date: 2024-09-16
Source: OpenAlex
DOI: 10.19080/jcmah.2024.13.555852
PubMed: Unavailable

Authors

Danielle B Rodrigues

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials2024-09-16

Related papers

Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept StudyClinicalTrials.gov · 2026-03-10 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02 Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary Clinical Trials · 2022-11-01